## Background: Mucosal oral squamous cell carcinoma (scc) accounts for 3-5% of all reported cancers, with a 5-year survival rate of approximately 50%. unfortunately, current detection means are of no value in diagnosing lesions early enough for cure, especially when they recur after resection. post
β¦ LIBER β¦
Serum fragment of cytokeratin subunit 19 (Cyfra) as a tumor marker in diagnosis and monitoring of treatment of oral squamous cell carcinoma
β Scribed by H. Kurokawa; Shingo Tokudome; Yoshihiro Yamashita; Hiroaki Ishibashi; Tsutomu Yoshikawa; Minoru Kajiyama
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 90 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1341-9625
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Early diagnosis and treatment monitoring
β
Rafael M. Nagler; Mira Barak; Micha Peled; Hanna Ben-Aryeh; Margarita Filatov; D
π
Article
π
1999
π
John Wiley and Sons
π
English
β 104 KB
π 1 views
Monitoring Cytokeratin Fragment 19 (CYFR
β
J.-J. Yeh; F.-Y. Liu; W.-H. Hsu; J.-J. Wang; S.-T. Ho; A. Kao
π
Article
π
2002
π
Springer
π
English
β 92 KB
Concentration of free hCGΞ² subunit in se
β
Johan HedstrΓΆm; Reidar Grenman; Hans Ramsay; Patrik Finne; Johan Lundin; Caj Hag
π
Article
π
1999
π
John Wiley and Sons
π
French
β 123 KB
π 1 views
This study was conducted to evaluate the clinical usefulness of serum hCGβ€ in the diagnosis and prognosis of patients (n β«Ψβ¬ 59) with cancers of the oral cavity and oropharynx. As a reference marker we used squamous-cell carcinoma antigen (SCCAg). A blood sample was obtained from all patients before
Serum ferritin as a tumor marker in pati
β
Peter E. Maxim; Robert W. Veltri
π
Article
π
1986
π
John Wiley and Sons
π
English
β 761 KB
Serum cross-linked carboxyterminal telop
β
Yoshihiro Nabeya; Hideaki Shimada; Shinichi Okazumi; Hisahiro Matsubara; Yoshio
π
Article
π
2002
π
John Wiley and Sons
π
English
β 108 KB
π 1 views